<DOC>
	<DOC>NCT02390349</DOC>
	<brief_summary>This randomized, placebo-controlled study evaluates the effects of CuraMed ® (BCM-95 ®) and Curamin ® in the treatment of osteoarthritis. One group will receive CuraMed, one group will receive Curamin and one group will receive placebo.</brief_summary>
	<brief_title>"CuraMed" and "Curamin" in Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<criteria>Patients with a diagnosis of degenerative hypertrophic osteoarthritis of the knee (M17, according to International Classification of Diseases (ICD10) of bone joints, verified by radiography (Grade 13 by KellgrenLawrence radiographic grades). subjects with inflammatory and any secondary arthritis moderate and severe synovitis (grades 2 and 3) tear of meniscus chronic diseases of the kidneys, liver, gastrointestinal, cardiovascular, endocrine and nervous systems allergic anamnesis and drug intolerance pregnant or nursing history of substance abuse subjects taking nonsteroidal antiinflammatory drugs and analgesics within 2 weeks prior to the study subjects taking glucosamine sulfate, chondroitin sulfate, intraarticular hyaluronate, systemic or intraarticular glucocorticoids within three months prior to the study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>